Skip To Main Content

English Español
Languages
English

Español

Search

Stay Informed: Latest News

A new option for hard-to-treat ovarian cancer is being evaluated

When eating is difficult: How to get good nutrition during cancer treatment

New study evaluates a medication for NSCLC with the KRAS G12C mutation

Dark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance

A new liver cancer trial explores a “two-in-one" treatment approach

Providence Cancer Institute secures three significant grants

Q&A: Meet one of the investigational drug pharmacists at Providence

New T-cell therapy for KRAS G12D cancers

Precision treatment for prostate cancer with MRI-guided radiation therapy

When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

Hope comes in a clinical trial: Brad’s remarkable story

Providence researchers head to Chicago for leading cancer conference

Adoptive cell therapy: Phase III study open for people with advanced melanoma

It started with one bandage, and a patient’s smile

New guidelines for treating head and neck cancer could be a game changer

Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments

VOICES of Black Women: A community study in cancer prevention and care

Leading the way: Providence researchers at AACR Annual Meeting

A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

Celebrating oncology social workers: Compassion, expertise and impact

6 things everyone should know about oncology palliative care

Clinical trial seeks better first-line therapy for follicular lymphoma

Where curiosity meets impact: Women in science at Providence Cancer Institute

Why patients in rural areas need access to quality clinical trials

A new strategy for treating locally advanced cervical cancer

Personalizing lymphoma treatment: New study seeks better outcomes

From patient to volunteer: Marge’s gift of gratitude

Reflecting on 2025, building toward 2026

Your year-end health checklist: Screenings, benefits and goals